Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 241-620-3 | CAS number: 17636-10-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
1. Acute oral toxicity (1987), GLP, OECD 401, rats, gavage, 2500 mg/kg, 3180 mg/kg, 4000 mg/kg, 5000 mg/kg, LD50 3720 mg/kg bw (14 day survival), 4110 mg/kg bw (24 hour survival).
2. Acute dermal toxicity (1987), GLP, OECD 402, rats, semiocclusive, 2.5 g/kg, 5.0 g/kg, 7.5 g/kg, LD50 > 7.5 g/kg bw.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: GLP-study with minor deficiencies in the report details
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: "Appraisal of the Safety of Chemicals in Foods, Drugs and Cosmetics", by the Staff of the Division of Pharmacology, FDA, 1959
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: SPF-Wistar rats (Breeder , Winkelmann, Paderborn, Germany )
- Weight at study initiation: ca 210 g
- Fasting period before study: 16 hours
- Housing: at random allocated to 4 groups, singly housed
- Diet (e.g. ad libitum): Laboratory standard diet (Altromin, Lage) ad libitum
- Water (e.g. ad libitum): ad libitum
ENVIRONMENTAL CONDITIONS
- Temperature:22°C ± 2°C,
- Humidity (%): 50 - 60 %
- Photoperiod (hrs dark / hrs light): 12 hours light and dark cycle - Route of administration:
- oral: gavage
- Vehicle:
- CMC (carboxymethyl cellulose)
- Details on oral exposure:
- Details on oral exposure: the suspension was applied to the animals orally by a rigid tube.
VEHICLE
- Concentration in vehicle: 25 % or 30 %
- Amount of vehicle (if gavage): 1 ml per 100 g bw
MAXIMUM DOSE VOLUME APPLIED: 1.7 ml per 100 g bw - Doses:
- 2500 mg/kg bw (25% solution), 3180 mg/kg bw (30% solution), 4000 mg/kg bw (30% solution), 5000 mg/kg bw (30% solution)
The animals in group I and II were given 1.0 ml per 100 g body weight, the animals in group III 1.3 ml/100 ml in group IV 1.7 ml per 100 g bw - No. of animals per sex per dose:
- 5 per sex per dose
- Control animals:
- not specified
- Details on study design:
- After 16 hours of fasting the animals received the substance via a rigid tube orally.
Then the animals were observed (individually housed) for 14 days and were evaluated using as criteria, the symptoms of poisoning, the clinical behaviour and occurring mortality. On 14th Day post applicationem the animals were killed, dissected and examined macroscopically for pathological changes. - Statistics:
- The LD50 oral was calculated according to Litchfield & Wilcoxon in combination with the Gauß's integral.
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 4 110 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 3 740 - 4 520
- Remarks on result:
- other: for 24 hour survival
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 3 720 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 3 380 - 4 090
- Remarks on result:
- other: for 14 day survival
- Sex:
- male/female
- Dose descriptor:
- LD0
- Effect level:
- 2 500 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: all animals survived
- Sex:
- male/female
- Dose descriptor:
- LD100
- Effect level:
- 5 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: within 24 hours all animals died
- Mortality:
- No animals died in the 2500 mg/kg bw dose group.
In the 3180 mg/kg bw dose group one animal died within the first 7 days.
In the 4000 mg/kg bw dose group 3 animals died within 24 hours and another 3 within the following 6 days.
All animals in the 5000 mg/kg bw dose group died within 24 hours. - Clinical signs:
- other: The results of intoxication were poisoning, characterized by ruffled hair coat, abdominal pain, proptosis, laboured respiration, tumbling and coordination disorders. In the highest dose group, these symptoms increased in a few hours from sedation to coma.
- Gross pathology:
- In the section of the acute deceased rats and in the end section the gross pathological investigations did not reveal any treatment-related macroscopic anatomical and pathological findings within the thoracic cavity of the skull. Macroscopic inspection of the section showed in the acute mortality hyperaemia in the stomach and intestines.
The end section showed hyperaemia in the intestinal tract, very bright kidneys and a flushed bright pancreas. - Other findings:
- no other findings reported
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The study was performed according to the OECD Guideline 401 without deviations and considered to be of high quality (reliability Klimisch 2). The validity criteria of the test system are fulfilled. The substance did not show a high toxicity after a single oral application to rats. The LD50 was identified to be 4110 mg/kg bw for the 24 h survival and 3720 mg/kg bw for the 14 day survival.
- Executive summary:
The acute oral toxicity of 1-Propanesulfonic acid, 3-mercapto-, monosodium salt (MPS) was investigated in rats (Dickhaus and Heisler, 1987). The rats received doses of 2500 mg/kg bw, 3180 mg/kg bw, 4000 mg/kg bw or 5000 mg/kg bw via a rigid tube intragastrically. The main symptoms of intoxications were ruffled hair coat, abdominal pain, proptosis, laboured respiration, tumbling and coordination disorders. All animals in the highest dose group died within 24 hours. In the 4000 mg/kg bw dose group 3 animals died within 24 hours and another 3 within the following 6 days. In the 3180 mg/kg bw dose group one animal died within the first 7 days. No animals died in the lowest dose group. Therefore the oral toxicity can be characterised by a LD50 value of 4110 mg/kg bw for a 24 hour survival and a 3720 mg/kg bw for a 14 day survival.
Reference
The acute symptoms of sedation increased into coma. The animals usually died within 24 hours post application, more animals died 48 and 72 hours post application.
Table 1: Clinical findings - weekly report for group 1
weekly report for clinical findings | |
testing period: 7 & 14 days p.a., group I = 2500 mg/kg, animal-no.:1-10 | |
Sex: 5 males +5 females | |
examination (macroscopically) | summary of findings |
behaviour | physiological, not special findings |
reflexes | jumpy |
fur, skin turgor | physiological, not special findings |
orifices | physiological, not special findings |
faeces (colour, consistency) | physiological, not special findings |
Bodyweights, food and water intake | decreased body weight gain, despite normal food and water intake |
acute symptoms | sedation, laboured breathing, abdominal pain |
weekly report for clinical findings | |
testing period: 7 & 14 days p.a., group: II = 3180 mg/kg, animal-no.:9 | |
Sex: 5 males +4 females | |
examination (macroscopically) | summary of findings |
behaviour | physiological, not special findings |
reflexes | decreased fur hygiene and jumpy behaviour |
fur, skin turgor | ruffled fur |
orifices | physiological, not special findings |
faeces (colour, consistency) | soft and smeary |
Bodyweights, food and water intake | decreased body weight gain, decreased food and water intake |
acute symptoms | sedation, laboured breathing, Sedation, exophthalmia, abdominal pain, coma and exitus letalis in one animal within the first 72 hours |
weekly report for clinical findings | |
testing period: 7 & 14 days p.a., group: III = 4000 mg/kg, animal-no.:4 | |
Sex: 2 males +2 females | |
examination (macroscopically) | summary of findings |
behaviour | physiological, not special findings |
reflexes | decreased fur hygiene and jumpy |
fur, skin turgor | ruffled fur, clean impression |
orifices | physiological, not special findings |
faeces (colour, consistency) | moist |
Bodyweights, food and water intake | decreased body weight gain, decreased food and water intake |
acute symptoms | 3 animals died within 24 hours and 3 died later with abdominal pain, cramps and coma within 72 hours after application |
weekly report for clinical findings | |
testing period: 7 & 14 days p.a. group: IV= 5000 mg/kg, animal-no.: 1 -10 | |
Sex: 5 males +5females | |
examination (macroscopically) | summary of findings |
behaviour | all animals died within 24 hours after application |
reflexes | |
fur, skin turgor | |
orifices | |
faeces (colour, consistency) | |
Bodyweights, food and water intake | |
acute symptoms | sedation (apathy and coma), exophthalmia and abdominal pain |
Table 5: single findings of acute toxicity testing - group 1
single findings of acute toxicity testing of 1-Propanesulfonic acid, 3-mercapto-, monosodium salt (8CI, 9 CI) | |||||||||
Group I, Project-no. 1-4-95-87, Species: rat, application: oral, date: June 1987 | |||||||||
No. | sex | dose | actual | body weight | mortalities |
body weight | symptoms |
||
(mg/kg) | dose | at start | 24 h | 48 h | 7 days | at end | (Irvin-screening) | ||
1 | m | 2500 | 2.12 | 212 | 264 | apathy, ataxia | |||
2 | m | 2500 | 2.16 | 216 | 262 | abdominal pain | |||
3 | m | 2500 | 2.16 | 216 | 268 | ||||
4 | m | 2500 | 2.12 | 212 | 252 | ruffled fur | |||
5 | m | 2500 | 2.10 | 210 | 250 | ||||
6 | f | 2500 | 2.04 | 204 | 216 | ||||
7 | f | 2500 | 2.06 | 206 | 212 | ||||
8 | f | 2500 | 2.02 | 202 | 210 | ||||
9 | f | 2500 | 2.04 | 204 | 209 | ||||
10 | f | 2500 | 2.08 | 208 | 218 | ||||
solvent: CMC, concentration 25 %, conduction of test: H. |
Table 6: single findings of acute toxicity testing - group 2
single findings of acute toxicity testing of 1-Propanesulfonic acid, 3-mercapto-, monosodium salt (8CI, 9 CI) | |||||||||
Group II, Project-no. 1-4-95-87, Species: rat, application: oral, date: June 1987 | |||||||||
No. | sex | dose | actual | body weight | mortalities | body weight | symptoms | ||
(mg/kg) | dose | at start | 24 h | 48 h | 7 days | at end | (Irvin-screening) | ||
1 | m | 3180 | 2.27 | 214 | 264 | apathy, ataxia | |||
2 | m | 3180 | 2.31 | 218 | 268 | abdominal pain, cramps | |||
3 | m | 3180 | 2.31 | 218 | 244 | exophthalmos | |||
4 | m | 3180 | 2.23 | 210 | 255 | ruffled fur and coma | |||
5 | m | 3180 | 2.26 | 213 | 250 | ||||
6 | f | 3180 | 2.14 | 202 | 214 | ||||
7 | f | 3180 | 2.16 | 204 | + | - | |||
8 | f | 3180 | 2.28 | 208 | 219 | ||||
9 | f | 3180 | 2.14 | 202 | 206 | ||||
10 | f | 3180 | 2.20 | 208 | 216 | ||||
solvent: CMC, concentration 30 %, conduction of test: H. |
Table 7: single findings of acute toxicity testing - group 3
single findings of acute toxicity testing of 1-Propanesulfonic acid, 3-mercapto-, monosodium salt (8CI, 9 CI) | |||||||||
Group III, Project-no. 1-4-95-87, Species: rat, application: oral, date: June 1987 | |||||||||
No. | sex | dose | actual | body weight | mortalities | body weight | symptoms | ||
(mg/kg) | dose | at start | 24 h | 48 h | 7 days | at end | (Irvin-screening) | ||
1 | m | 4000 | 2.88 | 216 | 252 | apathy, exophthalmos | |||
2 | m | 4000 | 2.88 | 216 | + | - | ataxia and sedation | ||
3 | m | 4000 | 2.91 | 218 | + | - | abdominal pain, and coma | ||
4 | m | 4000 | 2.80 | 210 | + | - | moribund | ||
5 | m | 4000 | 2.80 | 210 | 240 | ||||
6 | f | 4000 | 2.72 | 204 | + | - | |||
7 | f | 4000 | 2.72 | 204 | + | - | |||
8 | f | 4000 | 2.75 | 206 | + | - | |||
9 | f | 4000 | 2.75 | 206 | 204 | ||||
10 | f | 4000 | 2.77 | 208 | 216 | ||||
solvent: CMC, concentration 30 %, conduction of test: H. |
Table 8: single findings of acute toxicity testing - group 4
single findings of acute toxicity testing of 1-Propanesulfonic acid, 3-mercapto-, monosodium salt (8CI, 9 CI) | |||||||||
Group IV, Project-no. 1-4-95-87, Species: rat, application: oral, date: June 1987 | |||||||||
No. | sex | dose | actual | body weight | mortalities | body weight | symptoms | ||
(mg/kg) | dose | at start | 24 h | 48 h | 7 days | at end | (Irvin-screening) | ||
1 | m | 5000 | 3.57 | 214 | + | - | apathy, sedation | ||
2 | m | 5000 | 3.60 | 216 | + | - | abdominal pain, cramps, lacrimal secretion | ||
3 | m | 5000 | 3.63 | 218 | + | - | moribund | ||
4 | m | 5000 | 3.50 | 210 | + | - | |||
5 | m | 5000 | 3.55 | 213 | + | - | |||
6 | f | 5000 | 3.48 | 209 | + | - | |||
7 | f | 5000 | 3.45 | 207 | + | - | |||
8 | f | 5000 | 3.37 | 202 | + | - | |||
9 | f | 5000 | 3.37 | 202 | + | - | |||
10 | f | 5000 | 3.42 | 205 | + | - | |||
solvent: CMC, concentration 25 %, conduction of test: H. |
Table 9: observations (gross pathology) - group 1
organ | animal no. | Observations | ||||
CNS | group I - 10 animals | anat.-pathol. without specific findings | ||||
lung | " | anat.-pathol. without specific findings | ||||
heart/pericard | " | anat.-pathol. without specific findings | ||||
stomach | " | slightly hyperaemic | ||||
small/large intestine | " | slightly hyperaemic | ||||
liver | " | anat.-pathol. without specific findings | ||||
spleen | " | anat.-pathol. without specific findings | ||||
kidney | " | paler than normal, a little grainy | ||||
serosa/vessels | " | flushed pancreas, despite that without specific findings | ||||
lymph nodes | " | anat.-pathol. without specific findings | ||||
gonadal glands | " | anat.-pathol. without specific findings |
Table 10: observations (gross pathology) - group 2
organ | animal no. | Observations | ||||
CNS | group II - 9 animals | 1 animal died, anat.-pathol. without specific findings | ||||
lung | " | anat.-pathol. without specific findings | ||||
heart/pericard | " | anat.-pathol. without specific findings | ||||
stomach | " | anat.-pathol. without specific findings | ||||
small/large intestine | " | slightly hyperaemic | ||||
liver | " | anat.-pathol. without specific findings | ||||
spleen | " | anat.-pathol. without specific findings | ||||
kidney | " | paler than normal, a little grainy | ||||
serosa/vessels | " | flushed pancreas, despite that without specific findings | ||||
lymph nodes | " | anat.-pathol. without specific findings | ||||
gonadal glands | " | anat.-pathol. without specific findings |
Table 11: observations (gross pathology) - group 3
organ | animal no. | Observations | |||||
CNS | group III - 4 animals | 6 animals died, anat.-pathol. without specific findings | |||||
lung | " | anat.-pathol. without specific findings | |||||
heart/pericard | " | anat.-pathol. without specific findings | |||||
stomach | " | anat.-pathol. without specific findings | |||||
small/large intestine | " | hyperaemic, but anat.-pathol. Without specific findings | |||||
liver | " | anat.-pathol. without specific findings | |||||
spleen | " | anat.-pathol. without specific findings | |||||
kidney | " | paler than normal, a little grainy | |||||
serosa/vessels | " | flushed pancreas, despite that without specific findings | |||||
lymph nodes | " | anat.-pathol. without specific findings | |||||
gonadal glands | " | anat.-pathol. without specific findings |
Table 12: observations (gross pathology) - group 4
organ | animal no. | Observations | ||||||
CNS | all acute mortalities (mean of all groups) | anat.-pathol. without specific findings | ||||||
lung | " | anat.-pathol. without specific findings | ||||||
heart/pericard | " | anat.-pathol. without specific findings | ||||||
stomach | " | stomach and GIT-mucosa highly flushed and significantly hyperaemic | ||||||
small/large intestine | " | stomach and GIT-mucosa highly flushed and significantly hyperaemic | ||||||
liver | " | anat.-pathol. without specific findings | ||||||
spleen | " | anat.-pathol. without specific findings | ||||||
kidney | " | anat.-pathol. without specific findings | ||||||
serosa/vessels | " | anat.-pathol. without specific findings | ||||||
lymph nodes | " | anat.-pathol. without specific findings | ||||||
gonadal glands | " | anat.-pathol. without specific findings |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 3 720 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: GLP-study with minor deficiencies in the report details
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- no
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- other: "Appraisal for the Safety of Chemicals in Foods, Drugs and Cosmetics", by the Staff of the Division of Pharmacology, FDA 1959
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: SPF-Wistar rats (breeding Winkelmann, Paderborn, Germany)
- Weight at study initiation: ca. 210 g
- Housing: animals were kept in groups of 5 males and 5 females (divided at random) in individual cages
- Diet (e.g. ad libitum): laboratory standard diet (Altromin, Lage)
- Water (e.g. ad libitum): ad libitum
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ° C ± 2 ° C
- Humidity (%): 50 - 60%
- Photoperiod (hrs dark / hrs light): daily lighting for 12 hours. - Type of coverage:
- semiocclusive
- Vehicle:
- water
- Remarks:
- the product was diluted 1 to 1 with water, prior to application
- Details on dermal exposure:
- For reasons of optimal application of the substance and to allow good skin contact, the animals were shaved completely on the back. The entire trunk was wrapped with two layers of gauze and the undiluted substance was applied to the shaved localization. The treated area was covered with a thin plastic shell and coated with Stülpa. To avoid slipping, the whole body was bonded with adhesive tape, avoiding simultaneously oral ingestion and dehydration of the 1: 1 in water applied substance. The animals were left for 24 hours in this manner. Then the animals were carefully "unpacked" and cleaned with a wet, very warm cloth. The completely wet animals were individually dried by a hairdryer and only after reaching the "optimal cleaned" state, were put in individual farming. After dermal administration, the animals were observed individually housed for 14 days, were they were evaluated using as criteria, the symptoms of poisoning, the clinical behaviour and mortality.
- Duration of exposure:
- 24 h
- Doses:
- 2.5, 5.0 and 7.5 g/kg bw
- No. of animals per sex per dose:
- 5 males and females per dose
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: observations were conducted after 24 h, 48 h, after 7 and after 14 days, weighing was done at the beginning and the end of the study
- Necropsy of survivors performed: yes/no: yes (macroscopically examined for pathological changes)
- Other examinations performed: clinical signs, body weights - Statistics:
- No data given on statistical methods
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 7.5 other: g/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: No animals died
- Mortality:
- No mortalities occurred.
- Clinical signs:
- other: The animals behaved after the application a little more quiet than normal, which can be attributed to the bandage. After unpacking and in the further following-up period, the animals behaved physiologically.
- Gross pathology:
- In the end section no macroscopic anatomical or pathological findings in the belly, chest and skull were noted.
At the treated spinal sites there were no deviations from normal findings. The dorsal skin appeared subjectively in the highest dose group a little dry or leathery. - Other findings:
- no data
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The study was performed according to the OECD Guideline 402 without deviations and therefore considered to be of the highest quality (reliability Klimisch 1).The validity criteria of the test system was fulfilled. The test material did not induce any signs of acute dermal toxicity. The test material was considered to be not toxic via the dermal exposure route under the conditions of the test, which is based on the LD50 values derived from this study (LD50 > 7.5 g/kg bw).
- Executive summary:
The acute dermal toxicity of 1-Propanesulfonic acid, 3-mercapto-, monosodium salt (MPS) was investigated in rats (Dickhaus and Heisler, 1987). The substance was applied under semi-occlusive conditions to the skin for 24 h. No mortalities occurred and no clinical signs were reported. Therefore the test substance has an LD50 > 7.5 g/kg bw and can be regarded as non-toxic via the dermal exposure route.
Reference
Table 1: weekly protocol for clinical observations - group 1
testing period: 7 / 14 days p.a., group: I = 2,5 g/kg animal-no.:1-10 | |
Sex: 5 m + 5 f | |
examination (macroscopically) | summary of findings |
Appearance/ behaviour | physiological |
reflexes | physiological without special findings |
fur and skin turgor | physiological, hair was growing evenly |
orifices | physiological without special findings |
faeces (colour and consistency) | physiological without special findings |
body weight / food and water intake | normal body weight gain, normal food and water intake |
acute symptoms | none |
Table 2: weekly protocol for clinical observations - group 2
testing period: 7 / 14 days p.a., group: II = 5,0 g/kg animal-no.:1-10 | |
Sex: 5 m + 5 f | |
examination (macroscopically) | summary of findings |
Appearance/ behaviour | physiological |
reflexes | physiological without special findings |
fur and skin turgor | physiological, hair was growing evenly |
orifices | physiological without special findings |
faeces (colour and consistency) | physiological without special findings |
body weight / food and water intake | normal body weight gain, normal food and water intake |
acute symptoms | none |
Table 3: weekly protocol for clinical observations - group 3
testing period: 7 / 14 days p.a., group: III = 7,5 g/kg animal-no.:1-10 | |
Sex: 5 m + 5 f | |
examination (macroscopically) | summary of findings |
Appearance/ behaviour | physiological |
reflexes | physiological without special findings |
fur and skin turgor | physiological, hair was growing evenly |
orifices | physiological without special findings |
faeces (colour and consistency) | physiological without special findings |
body weight / food and water intake | normal body weight gain, normal food and water intake |
acute symptoms | none |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 7 500 mg/kg bw
Additional information
Acute oral toxicity:
The acute oral toxicity of 1-Propanesulfonic acid, 3-mercapto-, monosodium salt (MPS) was investigated in rats (Dickhaus and Heisler, 1987). The study was performed according to the OECD Guideline 401 without deviations and considered to be of high quality (reliability Klimisch 2). The validity criteria of the test system are fulfilled. 5 male and 5 female rats per group received doses of 2500 mg/kg bw, 3180 mg/kg bw, 4000 mg/kg bw or 5000 mg/kg bw via a rigid tube orally. The main symptoms of intoxications were ruffled hair coat, abdominal pain, proptosis, laboured respiration, tumbling and coordination disorders. All animals in the highest dose group died within 24 hours. In the 4000 mg/kg bw dose group 3 animals died within 24 hours and another 3 within the following 6 days. In the 3180 mg/kg bw dose group one animal died within the first 7 days. No animals died in the lowest dose group. Therefore the oral toxicity can be characterised by a LD50 value of 4110 mg/kg bw for a 24 hour survival and a 3720 mg/kg bw for a 14 day survival.
Acute dermal toxicity:
The acute dermal toxicity of 1-Propanesulfonic acid, 3-mercapto-, monosodium salt (MPS) was investigated in rats (Dickhaus and Heisler,1987). The study was performed according to the OECD Guideline 402 without deviations and therefore considered to be of the highest quality (reliability Klimisch 1). The validity criteria of the test system were fulfilled. The substance was resuspended in water (1:1) and applied semi-occlusive to the skin for 24 h. No mortalities occurred and no clinical signs were reported. The test material did not induce any signs of acute dermal toxicity. The test material was considered to be not toxic via the dermal exposure route under the conditions of the test, which is based on the LD50 values derived from this study (LD50 > 7.5 g/kg bw).
Prediction using TOXTREE (v2.5.0)
The chemical structure of 1-Propanesulfonic acid, 3-mercapto-, monosodium salt was assessed by Toxtree (v.2.5.0) modelling tool for its toxicity class according to the rules of Cramer (with extensions). 1-Propanesulfonic acid, 3-mercapto-, monosodium salt is allocated in the “TOXTREE Toxicity Class Low”, which is characteristically for substances with a simple chemical structure with efficient modes of metabolism suggesting a low order of oral toxicity.
Justification for selection of acute toxicity – oral endpoint
best study available
Justification for selection of acute toxicity – dermal endpoint
best study available
Justification for classification or non-classification
Acute oral toxicity:
According to OECD guideline 401 the LD50 cut-off of the test substance is 2000 mg/kg bw. According to the European regulation (EC) No. 1272/2008 the test item should not be classified as toxic via the oral route, since the LD50 is 3720 mg/kg bw.
Acute dermal toxicity:
According to the European regulation (EC) No. 1272/2008 the test material does not meet the criteria for classification and will not require labelling for dermal toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
